In other models IL-17+/IFNγ+ T cells have been suggested to play a role in pathogenicity; using the EAE murine model of MS, Murphy, et al. [33] demonstrated that these cells infiltrate the brain prior to the development of symptoms. This evidence concerns the gene IL17A and myeloid sarcoma.